Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OASIS-AF: Apixaban in Atrial Fibrillation and Ischemic Stroke with Prior Deep Intracerebral Hemorrhage
NCT07609654Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Oct 2026
- Primary completion
- Nov 2031
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in Atrial fibrillation (AFib), ischemic stroke, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)ischemic stroke
Beyond the preview
Go deeper on NCT07609654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07609654.